IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1167/iovs.07-1543 on April 25, 2008
 (Investigative Ophthalmology and Visual Science. 2008;49:3491-3498.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1543
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Figure
Right arrow All Versions of this Article:
iovs.07-1543v1
49/8/3491    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Koh, S.-W. M.
Right arrow Articles by Rutzen, A. R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koh, S.-W. M.
Right arrow Articles by Rutzen, A. R.

VIP and VIP Gene Silencing Modulation of Differentiation Marker N-Cadherin and Cell Shape of Corneal Endothelium in Human Corneas Ex Vivo

Shay-Whey M. Koh,1,2 Krish Chandrasekara,3 Cara J. Abbondandolo,1 Timothy J. Coll,1 and Allan R. Rutzen1

1From the Departments of Ophthalmology and Visual Sciences and 2Physiology, University of Maryland, Baltimore, Maryland; and 3Transgenetech, Columbia, Maryland.

PURPOSE. Vasoactive intestinal peptide (VIP) is expressed by corneal endothelial (CE) cells and is present in the aqueous humor, which bathes CE cells in vivo. This study demonstrated the role of CE cell VIP in maintaining the expression level of a CE differentiation marker, N-cadherin, and the hexagonal cell shape.

METHODS. To determine the most effective VIP concentration, bovine corneoscleral explants were treated with 0 (control) and 10–12 to 10–6 M VIP. Paired human corneas (nine donors) from an eye bank were used as control; the other corneas were treated with VIP. To silence endogenous VIP, paired fresh human donor corneas (from seven cadavers) were transduced with VIP shRNA or the control lentiviral particles and then bisected/quartered for quantitative analysis by semiquantitative RT-PCR (for mRNA) and Western blot analysis/immunocytochemistry (for protein), whereas alizarin red S staining revealed CE cell shape.

RESULTS. VIP concentration dependently increased bovine CE cell N-cadherin mRNA levels, with the maximal effect observed between 10–10 (1.47 ± 0.06-fold; P = 0.002) and 10–8 M VIP (1.48 ± 0.18-fold; P = 0.012). VIP (10–8 M) treatment increased N-cadherin protein levels in bovine and human CE cells to 1.98 ± 0.28-fold (P = 0.005) and 1.17 ± 0.10 (range, 0.91–1.87)-fold (P = 0.050) of their respective controls. VIP antagonist (SN)VIPhyb diminished the VIP effect. VIP silencing resulted in deterioration of the hexagonal cell shape and decreased levels of VIP protein and mRNA, N-cadherin (but not connexin-43) mRNA and protein, and the antiapoptotic Bcl-2 protein.

CONCLUSIONS. Through its autocrine VIP, CE cells play an active role in maintaining the differentiated state and suppressing apoptosis in the corneal endothelium in situ.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology